Latest Articles
Genetic Study: Fat Sites May Influence Cancer - Conexiant
Genetic Study: Fat Sites May Influence Cancer Conexiant
Published: Sept. 29, 2025, 5:06 p.m.
UC Cancer Center members present radiation oncology research at national conference - University of Cincinnati
UC Cancer Center members present radiation oncology research at national conference University of Cincinnati
Published: Sept. 29, 2025, 2:39 p.m.
Weight-loss drugs now linked to cancer protection in women, major new study reveals - WCCS AM1160 & 101.1FM
Weight-loss drugs now linked to cancer protection in women, major new study reveals WCCS AM1160 & 101.1FM
Published: Sept. 29, 2025, 11:37 a.m.
Weight-loss drugs now linked to cancer protection in women, major new study reveals - Fox News
Weight-loss drugs now linked to cancer protection in women, major new study reveals Fox News
Published: Sept. 29, 2025, 11 a.m.
'No human data' to support use of soursop leaf tea to cure cancer: experts - AFP Fact Check
'No human data' to support use of soursop leaf tea to cure cancer: experts AFP Fact Check
Published: Sept. 29, 2025, 9:39 a.m.
Insurance coverage for GSK's Jemperli expanded to 1st-line endometrial cancer in Korea - koreabiomed.com
Insurance coverage for GSK's Jemperli expanded to 1st-line endometrial cancer in Korea koreabiomed.com
Published: Sept. 29, 2025, 8:16 a.m.
Ibuprofen Use Linked to Lower Risk of Endometrial Cancer - Oncology Nurse Advisor
Ibuprofen Use Linked to Lower Risk of Endometrial Cancer Oncology Nurse Advisor
Published: Sept. 29, 2025, 4 a.m.
Vancouver Island women's cancer treatment could get an AI boost - Ladysmith Chemainus Chronicle
Vancouver Island women's cancer treatment could get an AI boost Ladysmith Chemainus Chronicle
Published: Sept. 28, 2025, 8:02 p.m.
Vancouver Island women's cancer treatment could get an AI boost - Vancouver Island Free Daily
Vancouver Island women's cancer treatment could get an AI boost Vancouver Island Free Daily
Published: Sept. 28, 2025, 2 p.m.
ASCENT-Gyn-01 Trial of Sacituzumab Govitecan Aims to Validate Clinical Utility of TROP2 ADCs in Pretreated Endometrial Cancer - OncLive
ASCENT-Gyn-01 Trial of Sacituzumab Govitecan Aims to Validate Clinical Utility of TROP2 ADCs in Pretreated Endometrial Cancer OncLive
Published: Sept. 26, 2025, 7:40 p.m.
Link copied to clipboard!